Allergy & Asthma Day Capitol Hill May 9, 2013
ALAA is joing with AANMA in urging Congress to take action to not allow asthma and anaphylaxis to be included in the FDA’s proposed new paradigm. To learn more - click on the links below. Watch for further updates.
Allergy & Asthma Network Mothers of Asthmatics (AANMA)
AANMA is urging Congress to take asthma and anaphylaxis medication out of FDA’s proposed paradigm. It would shift diagnosis and treatment decisions from physicians to patients, pharmacists and kiosks. Tell Congress that asthma and life-threatening allergies are NOT for “Do-It-Yourselfers”!
Learn more at www.aanma.org/advocacy/fda.
Add-on allergy testing and immunotherapy schemes are popping up in primary care practices across the country – exposing patients and families to less-than-professional diagnosis and therapy and raising a potential for fraud. AANMA is urging Congress to stop fraud and abuse of patients and families with allergies and asthma and support access to quality, patient-centered care!
Learn more at www.aanma.org/advocacy/deceptive-allergy-practices.